Neurovive (NEVPF) 0.6000 $NEVPF NeuroVive

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neurovive (NEVPF) 0.6000 $NEVPF

NeuroVive Pharmaceutical: NeuroVive Share Upgraded to OTC Markets Group - OTCQX Best Market in the US
BusinessWire - Thu Jun 02, 6:15AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive's R&D Team to Present Research Progress at Mitochondrial Medicine Conference
BusinessWire - Thu Apr 28, 2:14AM CDT
NeuroVive Pharmaceutical AB (STO:NVP) (publ), the pioneers in mitochondrial medicine, will present important research findings together with researchers at Lund University in three scientific poster presentations at the conference entitled "Mitochondrial Medicine: Developing New Treatments for Mitochondrial Disease" being held 4-6 May 2016 in Cambridge, United Kingdom.

NeuroVive Pharmaceutical: NeuroVive Starts Preclinical TBI Program in Collaboration with PENN
BusinessWire - Tue Apr 26, 8:38AM CDT
Regulatory News:

NeuroVive Pharmaceutical: NeuroVive Strengthens Its Organization with the Recruitment of Cecilia Hofvander as IR and Communications Director
BusinessWire - Mon Apr 11, 1:42AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive announces the CiPRICS study enrols 100 patients and reports favourable safety evaluation
BusinessWire - Mon Mar 14, 2:42AM CDT
Regulatory News:

NeuroVive Announces Departure of CEO and Appointment of Jan Nilsson as Interim CEO
BusinessWire - Tue Sep 01, 7:06AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive Share Upgraded on OTC Market in US
BusinessWire - Fri Jun 26, 10:28AM CDT
Regulatory News:

Neurovive Pharmaceutical: Neurovive Reports Topline Results of Phase III CIRCUS Study in Acute Myocardial Infarction
BusinessWire - Mon Jun 01, 1:47AM CDT
Regulatory News:

NeuroVive Asia Signs Collaboration Agreement with Sanofi for the Development and Commercialization of Ciclomulsion(R) in South Korea
BusinessWire - Tue May 26, 3:30AM CDT
Regulatory News:

Neurovive Pharmaceutical: Topline Result of Phase III Study of Ciclomulsion(R) in Acute Myocardial Infarction Expected This Quarter
BusinessWire - Mon May 25, 1:43AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive: Interim report 1 Jan. 2015 till 31 Mar. 2015
BusinessWire - Wed May 20, 1:54AM CDT
Regulatory News:

Global Ischemic Stroke Pipeline Report 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w6cj3m/ischemic_stroke) has announced the addition of the "Ischemic Stroke - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AB Science - Acorda Therapeutics, Inc. - Acticor Biotech - advanceCor GmbH - AGY Therapeutics, Inc. - Angion Biomedica Corp. - AstraZeneca PLC - Athersys, Inc. - Biogen Idec Inc. - BioTime, Inc. - D-Pharm Ltd. - Daiichi Sankyo Company, Limited - DiaMedica Inc. - Digna Biotech, S.L. - Genervon Biopharmaceuticals, LLC - GlaxoSmithKline plc - International Stem Cell Corporation - Laboratoires Pierre Fabre SA - Lumosa Therapeutics Co., Ltd. - MediaPharma s.r.l. - Mesoblast Limited - Mitsubishi Tanabe Pharma Corporation - Neuralstem, Inc. - Neurotec Pharma SL - NeuroVive Pharmaceutical AB - Panacea Pharmaceuticals, Inc. - Pharmicell Co., Ltd. - PhytoHealth Corporation - SanBio, Inc. - Saneron CCEL Therapeutics, Inc. - Simcere Pharmaceutical Group - Stemedica Cell Technologies, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/w6...mic_stroke
BIIB: 290.23 (+0.50), ACOR: 28.90 (-0.20), GSK: 42.89 (+0.48), AZN: 29.73 (+0.06), ATHX: 2.49 (+0.11), CUR: 0.35 (+0.01)

NeuroVive Pharmaceutical: NeuroVive Completes Share Issue Raising SEK 70 Million for the Preparation of CicloMulsion(R)'s Clinical Trial in the US and Commercialization in Europe
BusinessWire - Fri May 08, 1:33AM CDT
Regulatory News:

NeuroVive Announces the Intention to Raise Additional Capital Through a Private Placement
BusinessWire - Thu May 07, 10:50AM CDT
Regulatory News:

Neurovive Pharmaceutical: Clinical Phase II Study with NeuroSTAT(R) for Traumatic Brain Injury Passes Safety Evaluation
BusinessWire - Tue Apr 21, 3:06AM CDT
Regulatory News:

Neurovive Pharmaceutical: NeuroVive establishes subsidiary in Lyon and extends collaboration with HCL
BusinessWire - Mon Apr 20, 1:41AM CDT
Regulatory News:

NeuroVive Pharmaceutical: Development of NVP014 for the Treatment of Stroke Enters New Phase in Collaboration with Isomerase Therapeutics
BusinessWire - Fri Apr 17, 1:40AM CDT
Regulatory News:

NeuroVive Pharmaceutical reports change in number of shares and votes
M2 - Wed Apr 01, 3:06AM CDT
NeuroVive Pharmaceutical AB (STO:NVP), a mitochondrial medicine company, announced on Tuesday that the number of shares and votes of the company, registered with the Swedish Companies Registration Office, has increased by 1,300,000.

OnCore Biopharma and Tekmira Pharmaceuticals Files for Merger - Releases Further Details about License Agreement With NeuroVive
BusinessWire - Thu Feb 05, 2:28AM CST
Regulatory News:
TKMR: 10.83 (+0.58)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spotlight on Disability Inclusivity: 10 Honorees Celebrated

Updated Category News Views 21

Celebrating Champions of Inclusivity April 17, 2026 was a red-letter day for hope and progress in Garden Grove. The Regional Center of Orange County (RCOC) hosted its 29th annual Spotlight Awards, tipping their hats to ten trailblazing individuals and organizations. In a society where the marginalized often get left out of the success parade, these folks are ahead of the...

Continue Reading
Essential Oils Market Booms; Hits $29.52Bn by 2031

Updated Category News Views 103

Essential Oils: Aromatherapy's New Frontier and Pharma Ally What’s the deal with essential oils? Well, it seems they’re not just for your neighbor’s pricey diffuser anymore. According to some fresh numbers, we're staring down a market worth nearly $30 billion by 2031. And it ain't all incense and hippie stores fueling this beast — we're talking a serious expansion...

Continue Reading
Proterra's New Hire Targets Credit Expansion Ambitions

Updated Category News Views 62

In the high-stakes world of leveraged finance, it's not always easy to stand out. Yet here we are, with Proterra Investment Partners snagging a seasoned vet, Eric Rogowski, for their credit squad. This ain't just window dressing; we're talking about real moves to beef up Proterra’s credit origination capacity—especially in the food, beverage, and agribusiness sectors....

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 0

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Navigating Market Uncertainty with Financial Planning

Updated Category News Views 14

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading
Antibiotic Overuse for Sinus Infections Costs Billions

Updated Category News Views 21

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 20

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Meta's Bold Move: $25B Offering and New Stocks

Updated Category News Views 38

Meta's New Financial Adventure Well, when Meta talks money, you better believe the market listens. This time, they’ve got a whopping pair of offerings on the table—one for depositary shares and another for their Class A common stock. Meta, under the ticker NASDAQ:META, isn't holding back, with a $25 billion upsized offering that's bound to rattle some cages. A Deeper...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 56

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading

Top 5 Most Recently Viewed Articles

LeoStella and BlackSky Propel Space Innovation through HALO

Updated Category News Views 130

LeoStella and BlackSky Join Forces for Space Development In a significant advancement in space technology, LeoStella has been chosen by the Space Development Agency (SDA) to participate in the Hybrid Acquisition for Proliferated Low-Earth Orbit (HALO) program. This project marks an exciting turn for nontraditional defense firms, allowing them to engage directly with SDA...

Continue Reading
Medical Care Technologies Implements Strategic Share Reduction

Updated Category News Views 94

Medical Care Technologies Initiates Share Reduction Plan Medical Care Technologies Inc. (MDCE) / Infinite Auctions has embarked on an important initiative to enhance its financial health and shareholder value by reducing the outstanding share count. This initial step involves slashing 200 million shares in what the company refers to as Phase One of this strategic plan....

Continue Reading
Innovent's Arcotatug Tavatecan: A Potential Game Changer

Updated Category News Views 14

Innovent's New Kid on the Block Alright, let's dive into the nitty-gritty of Innovent Biologics and their latest scientific marvel, arcotatug tavatecan. It's not every day you hear about a potential game-changer in the oncology world, but this CLDN18.2-targeted ADC seems to be creating quite the stir. For a company founded with the mission of making high-quality medicines...

Continue Reading
SolarBank Set to Announce Annual Results and Host Webinar Event

Updated Category News Views 87

SolarBank to Share Annual Financial Results SolarBank Corporation (CSE: SUNN, NASDAQ: SUUN) is preparing to unveil its annual financial results, an important occasion for both stakeholders and investors. Recently, the company announced it would release its results for the year ending June 30, 2024, following the close of trading on the Nasdaq market. An engaging webinar...

Continue Reading
Reviewing the Sprinklr Class Action Filing: What to Know for Investors

Updated Category News Views 235

Understanding the Class Action Lawsuit Involving Sprinklr, Inc. Investors today are continuously seeking secure avenues for their financial assets. However, events can unfold that may alter their initial expectations. The latest developments surrounding Sprinklr, Inc. (NYSE: CXM) have prompted an important class action announcement. This notice is crucial for shareholders...

Continue Reading